Global Insulin (Medication) Market Research Report to 2020

June 2016 | 121 pages | ID: G4C3FD6F4C8EN
QYResearch

Abstracts

The global insulin market is estimated to grow at a CAGR of 8% during the forecast period, to reach USD 40 Billion by 2020. Although share less than 40% of diabetes market, insulins keep a higher increase rate. The share of insulin manufactures is highly concentrated. The top seven insulin drugs all come from three companies, whose total sales has reached USD 20 billion in 2015.

This report studies Insulin (Medication) in Global market, especially in USA, EU, China, Japan, Southeast Asia and India, focuses on top players in these countries, with sales, price, revenue and market share in Global market, like

• Novo Nordisk (Denmark)
• Sanofi (France)
• Eli Lilly and Company (U.S.)
• Biocon Ltd. (India)
• Julphar (U.A.E.)
• Wockhardt Ltd.(India)
• Biodel Inc. (U.S.)
• Wanbang Biopharma Co. (China)
• Dongbao Enterprise Group Co. (China)
• Bioton (Poland)
• Piramal Healthcare (India)
• USV Limited (India)
• Ganlee (China)

Market Segment by Regions, this report splits Global into several key countries, with sales (consumption), revenue, market share and growth rate of Insulin (Medication) in these countries, from 2011 to 2020 (forecast), like

• USA
• China
• EU
• Japan
• Southeast Asia
• India
• Rest of Global

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Long-Acting Insulin
• Rapid-Acting Insulin
• Short-Acting Insulin
• Intermediate-Acting Insulin
• Premixed Insulin

Split by applications, this report focuses on consumption, market share and growth rate of Insulin (Medication) in each application, can be divided into

• Type 1 Diabetes mellitus
• Type 2 Diabetes mellitus

Contents

1 INSULIN (MEDICATION) OVERVIEW

1.1 Product Overview and Scope of Insulin (Medication)
1.2 Insulin (Medication) Segment by Type
  1.2.1 Long-Acting Insulin and Sales Growth Rate 2011-2020
  1.2.2 Rapid-Acting Insulin and Sales Growth Rate 2011-2020
  1.2.3 Short-Acting Insulin and Sales Growth Rate 2011-2020
  1.2.4 Intermediate-Acting Insulin and Sales Growth Rate 2011-2020
  1.2.5 Premixed Insulin and Sales Growth Rate 2011-2020
1.3 Insulin (Medication) Segment by Applications
  1.3.1 Insulin (Medication) Sales Market Share by Applications in 2015 and 2016
  1.3.2 Type 1 Diabetes mellitus
  1.3.3 Type 2 Diabetes mellitus
1.4 Insulin (Medication) Market by Regions
  1.4.1 USA Status and Prospect 2011-2020
  1.4.2 China Status and Prospect 2011-2020
  1.4.3 EU Status and Prospect 2011-2020
  1.4.4 Japan Status and Prospect 2011-2020
  1.4.5 Southeast Asia Status and Prospect 2011-2020
  1.4.6 India Status and Prospect 2011-2020
1.5 Global Market Size (Value and Volume) of Insulin (Medication) 2011-2020
  1.5.1 Global Insulin (Medication) Sales and Growth Rate 2011-2020
  1.5.2 Global Insulin (Medication) Revenue and Growth Rate 2011-2020

2 GLOBAL INSULIN (MEDICATION) MARKET COMPETITION BY MANUFACTURERS

2.1 Global Insulin (Medication) Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Insulin (Medication) Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Insulin (Medication) Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Insulin (Medication) Manufacturing Base Distribution and Product Type

3 GLOBAL INSULIN (MEDICATION) MARKET ANALYSIS BY TYPE AND APPLICATIONS

3.1 Global Insulin (Medication) Sales, Market Share and Growth Rate by Type 2011-2020
3.2 Global Insulin (Medication) Revenue, Market Share and Growth Rate by Type 2011-2020
3.3 Insulin (Medication) Average Price by Type in 2015
3.4 Global Insulin (Medication) Sales, Market Share and Growth Rate by Applications 2011-2020

4 GLOBAL INSULIN (MEDICATION) MANUFACTURERS ANALYSIS

4.1 Novo Nordisk (Denmark)
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Insulin (Medication) Product Type and Technology
    4.1.2.1 NovaRapid/Novolog Price and Specification
    4.1.2.2 Levemir Price and Specification
    4.1.2.3 Human insulin Price and Specification
    4.1.2.4 NovaMix Price and Specification
  4.1.3 Insulin (Medication) Sales, Revenue, Price of Novo Nordisk 2015 to 2016
4.2 Sanofi (France)
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Insulin (Medication) Product Type and Technology
    4.2.2.1 Lantus Price and Specification
    4.2.2.2 Apidra Price and Specification
    4.2.2.3 Toujeo Price and Specification
    4.2.2.4 Insuman Price and Specification
    4.2.2.5 Aferzza Price and Specification
  4.2.3 Insulin (Medication) Sales, Revenue, Price of Sanofi 2015 to 2016
4.3 Eli Lilly and Company (U.S.)
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Insulin (Medication) Product Type and Technology
    4.3.2.1 Humalog Price and Specification
    4.3.2.2 Humanlin Price and Specification
    4.3.2.3 Basaglar Price and Specification
  4.3.3 Insulin (Medication) Sales, Revenue, Price of Eli Lilly and Company 2015 to 2016
4.4 Biocon Ltd. (India)
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Insulin (Medication) Product Type and Technology
    4.4.2.1 Recombinant Human Insulin (rh-Insulin) Price and Specification
    4.4.2.2 Insulin Glargine Price and Specification
    4.4.2.3 Insulin Aspart Price and Specification
    4.4.2.4 Insulin Lispro Price and Specification
  4.4.3 Insulin (Medication) Sales, Revenue, Price of Biocon Ltd. 2015 to 2016
4.5 Julphar (U.A.E.)
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Insulin (Medication) Product Type and Technology
    4.5.2.1 INSULIN (API) Price and Specification
    4.5.2.2 JUSLINE 30/70 Price and Specification
    4.5.2.3 JUSLINE N Price and Specification
    4.5.2.4 JUSLINE R Price and Specification
  4.5.3 Insulin (Medication) Sales, Revenue, Price of Julphar 2015 to 2016
4.6 Wockhardt Ltd.( India)
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Insulin (Medication) Product Type and Technology
    4.6.2.1 Wosulin Price and Specification
    4.6.2.2 Glaritus Price and Specification
  4.6.3 Insulin (Medication) Sales, Revenue, Price of Wockhardt Ltd. 2015 to 2016
4.7 Biodel Inc. (U.S.)
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Insulin (Medication) Product Type and Technology
    4.7.2.1 RHI-Based Ultra-Rapid-Acting Insulin Price and Specification
    4.7.2.2 Analog-Based Ultra-Rapid-Acting Insulin Price and Specification
    4.7.2.3 Concentrated Ultra-Rapid-Acting Insulin Price and Specification
  4.7.3 Insulin (Medication) Sales, Revenue, Price of Biodel Inc. 2015 to 2016
4.8 Wanbang Biopharma Co. (China)
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Insulin (Medication) Product Type and Technology
    4.8.2.1 CLONEPO Price and Specification
    4.8.2.2 CICLEADON Price and Specification
    4.8.2.3 CLONGAMMA Price and Specification
  4.8.3 Insulin (Medication) Sales, Revenue, Price of Wanbang Biopharma Co. 2015 to 2016
4.9 Dongbao Enterprise Group Co. (China)
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Insulin (Medication) Product Type and Technology
    4.9.2.1 Gansulin R Price and Specification
    4.9.2.2 Gansulin N Price and Specification
    4.9.2.3 Gansulin 30R Price and Specification
  4.9.3 Insulin (Medication) Sales, Revenue, Price of Dongbao Enterprise Group Co. 2015 to 2016
4.10 Bioton (Poland)
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Insulin (Medication) Product Type and Technology
    4.10.2.1 Recombinant human insulin Price and Specification
  4.10.3 Insulin (Medication) Sales, Revenue, Price of Bioton 2015 to 2016
4.11 Piramal Healthcare (India)
  4.11.1 Company Basic Information, Manufacturing Base and Competitors
  4.11.2 Insulin (Medication) Product Type and Technology
    4.11.2.1 Actrapid 100iu/40iu Price and Specification
    4.11.2.2 Actrapid HM Price and Specification
  4.11.3 Insulin (Medication) Sales, Revenue, Price of PIRAMAL HEALTHCARE 2015 to 2016
4.12 USV Limited (India)
  4.12.1 Company Basic Information, Manufacturing Base and Competitors
  4.12.2 Insulin (Medication) Product Type and Technology
    4.12.2.1 Pramlintide Price and Specification
  4.12.3 Insulin (Medication) Sales, Revenue, Price of USV Limited 2015 to 2016
4.13 Ganlee (China)
  4.13.1 Company Basic Information, Manufacturing Base and Competitors
  4.13.2 Insulin (Medication) Product Type and Technology
    4.13.2.1 Basalin Price and Specification
    4.13.2.2 Prandilin Price and Specification
    4.13.2.3 Prandilin 25R Price and Specification
  4.13.3 Insulin (Medication) Sales, Revenue, Price of Ganlee 2015 to 2016

5 GLOBAL INSULIN (MEDICATION) MARKET ANALYSIS BY REGIONS

5.1 USA Insulin (Medication) Market
  5.1.1 USA Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020
  5.1.2 USA Insulin (Medication) Sales and Market Share by Manufacturers in 2015
  5.1.3 USA Insulin (Medication) Sales and Market Share by Type in 2015
  5.1.4 USA Insulin (Medication) Sales and Market Share by Applications in 2015
5.2 China Insulin (Medication) Market
  5.2.1 China Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020
  5.2.2 China Insulin (Medication) Sales and Market Share by Manufacturers in 2015
  5.2.3 China Insulin (Medication) Sales and Market Share by Type in 2015
  5.2.4 China Insulin (Medication) Sales and Market Share by Applications in 2015
5.3 EU Insulin (Medication) Market
  5.3.1 EU Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020
  5.3.2 EU Insulin (Medication) Sales and Market Share by Manufacturers in 2015
  5.3.3 EU Insulin (Medication) Sales and Market Share by Type in 2015
  5.3.4 EU Insulin (Medication) Sales and Market Share by Applications in 2015
5.4 Japan Insulin (Medication) Market
  5.4.1 Japan Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020
  5.4.2 Japan Insulin (Medication) Sales and Market Share by Manufacturers in 2015
  5.4.3 Japan Insulin (Medication) Sales and Market Share by Type in 2015
  5.4.4 Japan Insulin (Medication) Sales and Market Share by Applications in 2015
5.5 Southeast Asia Insulin (Medication) Market
  5.5.1 Southeast Asia Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020
  5.5.2 Southeast Asia Insulin (Medication) Sales and Market Share by Manufacturers in 2015
  5.5.3 Southeast Asia Insulin (Medication) Sales and Market Share by Type in 2015
  5.5.4 Southeast Asia Insulin (Medication) Sales and Market Share by Applications in 2015

6 INSULIN (MEDICATION) TECHNOLOGY AND DEVELOPMENT TREND

6.1 Insulin (Medication) Technology Analysis
  6.1.1 Research Progress of Inhaled Insulin
    6.1.1.1 Inhaled Insulin Products in Research or in Clinical Trial
    6.1.1.2 Development Trend for Inhaled Insulin
  6.1.2 Research Progress of Oral Insulin
    6.1.2.1 Oral Insulin Products in Research or in Clinical Trial
    6.1.2.2 Development Trend Oral Insulin
  6.1.3 Research Progress of Other New Insulin
  6.1.4 Development of Insulin Devices
6.2 Insulin (Medication) Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Insulin (Medication)
Figure Picture of Long-Acting Insulin
Figure Long-Acting Insulin Sales Growth Rate 2011-2020
Figure Picture of Rapid-Acting Insulin
Figure Rapid-Acting Insulin Sales Growth Rate 2011-2020
Figure Picture of Short-Acting Insulin
Figure Short-Acting Insulin Sales Growth Rate 2011-2020
Figure Picture of Intermediate-Acting Insulin
Figure Intermediate-Acting Insulin Sales Growth Rate 2011-2020
Figure Picture of Premixed Insulin
Figure Premixed Insulin Sales Growth Rate 2011-2020
Table Insulin (Medication) Sales Market Share by Applications in 2015 and 2016
Table Insulin (Medication) Key Clients (Buyers) List in Type 1 Diabetes mellitus
Table Insulin (Medication) Key Clients (Buyers) List in Type 2 Diabetes mellitus
Figure USA Insulin (Medication) Sales and Growth Rate 2011-2020
Figure China Insulin (Medication) Sales and Growth Rate 2011-2020
Figure EU Insulin (Medication) Sales and Growth Rate 2011-2020
Figure Japan Insulin (Medication) Sales and Growth Rate 2011-2020
Figure Southeast Asia Insulin (Medication) Sales and Growth Rate 2011-2020
Figure India Insulin (Medication) Sales and Growth Rate 2011-2020
Figure Global Insulin (Medication) Sales and Growth Rate 2011-2020
Figure Global Insulin (Medication) Revenue and Growth Rate 2011-2020
Table Global Insulin (Medication) Sales of Key Manufacturers (2015 and 2016)
Table Global Insulin (Medication) Sales Share by Manufacturers (2015 and 2016)
Table Global Insulin (Medication) Revenue by Manufacturers (2015 and 2016)
Table Global Insulin (Medication) Revenue Share by Manufacturers (2015 and 2016)
Table Global Market Insulin (Medication) Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers Insulin (Medication) Manufacturing Base Distribution and Product Type
Table Global Insulin (Medication) Sales by Type 2011-2020
Table Global Insulin (Medication) Sales Share by Type 2011-2020
Table Global Insulin (Medication) Sales Growth Rate by Type 2011-2020
Table Global Insulin (Medication) Revenue by Type 2011-2020
Table Global Insulin (Medication) Revenue Share by Type 2011-2020
Table Global Insulin (Medication) Revenue Growth Rate by Type 2011-2020
Table Insulin (Medication) Average Price by Type in 2015
Table Global Insulin (Medication) Sales by Type 2 Diabetes mellitus011-2020
Table Global Insulin (Medication) Sales Market Share by Type 2 Diabetes mellitus011-2020
Table Global Insulin (Medication) Sales Growth Rate by Type 2 Diabetes mellitus011-2020
Table Novo Nordisk Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Novo Nordisk 2015 to 2016
Table Sanofi Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Sanofi 2015 to 2016
Table Eli Lilly and Company Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Eli Lilly and Company 2015 to 2016
Table Biocon Ltd. Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Biocon Ltd. 2015 to 2016
Table Julphar Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Julphar 2015 to 2016
Table Wockhardt Ltd. Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Wockhardt Ltd. 2015 to 2016
Table Biodel Inc. Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Biodel Inc. 2015 to 2016
Table Wanbang Biopharma Co. Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Wanbang Biopharma Co. 2015 to 2016
Table Dongbao Enterprise Group Co. Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Dongbao Enterprise Group Co. 2015 to 2016
Table Bioton Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Bioton 2015 to 2016
Table PIRAMAL HEALTHCARE Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of PIRAMAL HEALTHCARE 2015 to 2016
Table USV Limited Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of USV Limited 2015 to 2016
Table Ganlee Basic Information List
Table Insulin (Medication) Sales, Revenue, Price of Ganlee 2015 to 2016
Figure USA Insulin (Medication) Sales and Growth Rate 2011-2020
Figure USA Insulin (Medication) Revenue and Growth Rate 2011-2020
Table USA Insulin (Medication) Sales and Market Share by Manufacturers in 2015
Table USA Insulin (Medication) Sales and Market Share by Type in 2015
Table USA Insulin (Medication) Sales and Market Share by Applications in 2015
Figure China Insulin (Medication) Sales and Growth Rate 2011-2020
Figure China Insulin (Medication) Revenue and Growth Rate 2011-2020
Table China Insulin (Medication) Sales and Market Share by Manufacturers in 2015
Table China Insulin (Medication) Sales and Market Share by Type in 2015
Table China Insulin (Medication) Sales and Market Share by Applications in 2015
Figure EU Insulin (Medication) Sales and Growth Rate 2011-2020
Figure EU Insulin (Medication) Revenue and Growth Rate 2011-2020
Table EU Insulin (Medication) Sales and Market Share by Manufacturers in 2015
Table EU Insulin (Medication) Sales and Market Share by Type in 2015
Table EU Insulin (Medication) Sales and Market Share by Applications in 2015
Figure Japan Insulin (Medication) Sales and Growth Rate 2011-2020
Figure Japan Insulin (Medication) Revenue and Growth Rate 2011-2020
Table Japan Insulin (Medication) Sales and Market Share by Manufacturers in 2015
Table Japan Insulin (Medication) Sales and Market Share by Type in 2015
Table Japan Insulin (Medication) Sales and Market Share by Applications in 2015
Figure Southeast Asia Insulin (Medication) Sales and Growth Rate 2011-2020
Figure Southeast Asia Insulin (Medication) Revenue and Growth Rate 2011-2020
Table Southeast Asia Insulin (Medication) Sales and Market Share by Manufacturers in 2015
Table Southeast Asia Insulin (Medication) Sales and Market Share by Type in 2015
Table Southeast Asia Insulin (Medication) Sales and Market Share by Applications in 2015